Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma
Abroad (travel likely)RecruitingPHASE3
Conditions
Nasopharyngeal Carcinoma · High-Risk Cancer · Maintenance Therapy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Ganzhou Cancer Hospital, Ganzhou, Jiangxi, China
Contact: Study coordinator (Wei Wu, M.D.)Contact: Principal Investigator (Wei Wu, M.D.)Songhuan Lin, M.D. (Sub-investigator)First Affiliated hospital of Gannan Medical University, Guangzhou, Jiangxi, China
Contact: Study coordinator (Mingjun Xu, MD)Contact: Principal Investigator (Mingjun Xu, MD)Renwang Chen, PhD (Sub-investigator)Department of Nasopharyngeal Carcinoma, Jiangxi Cancer Hospital, Nanchang, None Selected, China
Contact: Principal Investigator (Jingao Li, PhD)Xiaochang Gong, MD (Sub-investigator)
Study leads
Jingao Li
Study Chair
Jiangxi Provincial Cancer Hospital